- Home
- LTBR vs NBP Comparison
LTBR vs NBP Comparison
Compare LTBR & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTBR | NBP |
|---|---|---|
| Founded | 1992 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 575.6M | 503.8M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | LTBR | NBP |
|---|---|---|
| Price | $12.79 | $3.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | ★ 1.0M | 632.4K |
| Earning Date | 02-25-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.10 | $0.60 |
| 52 Week High | $31.34 | $6.79 |
Technical Indicators
Market Signals| Indicator | LTBR | NBP |
|---|---|---|
| Relative Strength Index (RSI) | 37.91 | 38.02 |
| Support Level | $13.26 | $3.29 |
| Resistance Level | $15.15 | $3.74 |
| Average True Range (ATR) | 1.54 | 0.24 |
| MACD | -0.39 | -0.02 |
| Stochastic Oscillator | 0.84 | 17.07 |
Price Performance
Historical ComparisonAbout LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.